Recent Updates
Recently added Catalysts
NTHI Positive Sentiment

NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout

Monday, August 10, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: NeOnc Technologies Holdings, Inc. has released its financial results for the second quarter of 2026. The company confirmed that it will present topline data from its Phase 2a NEO100 trial on August 12. NeOnc is focused on developing treatments for central nervous system cancers, highlighting its commitment to innovation in this area.

Market Sentiment Analysis

POSITIVE FACTORS

  • NeOnc reported financial results indicating growth.
  • Confirmation of upcoming Phase 2a NEO100 data readout.
  • Focus on innovative treatments for central nervous system cancers.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Cash runway
~0 mo
High dilution risk
Lead asset
Perillyl alcohol
Phase 1 · Glioblastoma Multiforme

Full Press Release Details

CALABASAS, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) (“NeOnc” or the “Company”), a clinical-stage biopharmaceutical company developing innovative treatments for central nervous system cancers, today announced financial results for the second quarter

Frequently Asked Questions

What were NeOnc's financial results for Q2 2026?

NeOnc reported its financial results for the second quarter of 2026, indicating growth.

When will NeOnc present Phase 2a NEO100 data?

NeOnc will present topline data from its Phase 2a NEO100 trial on August 12.

What is the focus of NeOnc Technologies?

NeOnc is focused on developing innovative treatments for central nervous system cancers.

ShareAdd on Google
Tags: NTHI Viatris Investor Conferences Healthcare NeOnc Phase 2a NEO100 financial results
Last updated: Aug 10, 2026

Biotech snapshot

Cash runway
$0M liquidity · $2M/mo burn
~0 mo
High dilution risk
Lead asset
Perillyl alcoholPhase 1
Glioblastoma Multiforme →